+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Forecast 2024-2030- Product Image
Global Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Forecast 2024-2030- Product Image
Sale

Global Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968139
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coagulation Testing Market size was estimated at USD 4.62 billion in 2023, USD 5.07 billion in 2024, and is expected to grow at a CAGR of 9.92% to reach USD 8.96 billion by 2030.

Coagulation testing encompasses a range of diagnostic procedures aimed at assessing the blood's ability to clot properly. These tests are critical in diagnosing and managing various conditions that affect the blood's clotting capability, such as hemophilia, thrombosis, and liver disease. They are also essential in monitoring patients on anticoagulation therapy to ensure safe and effective treatment outcomes. The rising prevalence of cardiovascular diseases and blood disorders has increased the adoption of coagulation testing. Additionally, the aging global population at higher risk of blood-related disorders also significantly raises the need for coagulation testing.

However, the high cost of coagulation testing devices and stringent regulatory requirements for the new devices' approval delay product launches, affecting market dynamics. Despite these challenges, increasing investment in healthcare infrastructure in emerging economies provides a future growth prospect. Furthermore, ongoing research and development activities aiming to introduce innovative and efficient coagulation testing solutions are expected to offer new avenues for expansion.

Regional Insights

In the Americas, coagulation testing is getting highly adopted owing to the high prevalence of cardiovascular diseases and an increasing aging population, particularly in North America. The United States showcases higher adoption, supported by advanced healthcare infrastructure and favorable reimbursement policies. The EMEA region presents diverse scenarios in the coagulation testing market, with Europe having a high adoption rate. The growth in Europe is spurred by the increasing adoption of point-of-care (POC) testing devices for faster and more efficient diagnosis, alongside strong healthcare systems and a higher level of patient awareness.

The Middle East and Africa are witnessing gradual growth, with initiatives by governments and NGOs to improve healthcare facilities. Asia-Pacific is projected to be the biggest market for coagulation testing, driven by rapidly developing healthcare infrastructure and a large patient pool. Countries inclduing China and India are at the forefront of the adoption of coagulation testing, with their growing middle-class populations and increased focus on healthcare reform. Furthermore, the expanding research and development activities in the region to develop affordable testing solutions are expected to boost the market in this region.

Market Trends by Segment

  • Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
  • End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need

Roche has introduced three new coagulation tests for the oral Factor Xa inhibitors apixaban, edoxaban, and rivaroxaban, available in countries recognizing the CE mark. Roche aims to enhance lab efficiency with their tests' compatibility with cobas t analysers and innovative Anti-Xa cassette technology, which standardizes the testing process and minimizes user intervention, contamination, and evaporation risks, thus facilitating a streamlined and more effective use of reagents and potentially improving patient outcomes.

HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023

HORIBA has announced the expansion of its coagulation testing capabilities in the UK with the introduction of its cutting-edge, fully automated haemostasis analysers, the high-throughput Yumizen G1500h/G1550h and the compact Yumizen G800h/G850h models. These advanced systems are engineered to elevate precision by efficiently pinpointing and analyzing HIL interferences (haemolysis, icterus, and lipemia) in each coagulation test, alongside automatically assessing the primary tubes for adequacy of fill levels.

Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers

Diagnostica Stago has achieved a significant milestone with the US Food and Drug Administration's 510(k) clearance for its latest Max Generation analyzers, the STA R Max3 and STA Compact Max3, designed to improve the diagnosis and monitoring of coagulation disorders and anticoagulant therapy. Engineered with cutting-edge features, these fully automated analyzers provide comprehensive testing capabilities such as clot-based, immunoturbidimetric, and colorimetric assessments.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

This research report offers invaluable insights into various crucial aspects of the Coagulation Testing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of coagulation disorders worldwide
5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
5.1.2. Restraints
5.1.2.1. Lack of reimbursements for coagulation testing
5.1.3. Opportunities
5.1.3.1. Advancements in coagulation testing technologies
5.1.3.2. Emergence of coagulation testing for homecare
5.1.4. Challenges
5.1.4.1. Technical limitations and inaccuracies of coagulation testing
5.2. Market Segmentation Analysis
5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Coagulation Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. Coagulation Testing Market, by Test Type
7.1. Introduction
7.2. Activated Partial Thromboplastin Time
7.3. Prothrombin Time
7.4. Thrombin Time
8. Coagulation Testing Market, by End-User
8.1. Introduction
8.2. Clinical Laboratories
8.3. Home Testing
8.4. Hospitals
9. Americas Coagulation Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Coagulation Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Coagulation Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COAGULATION TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 52. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 53. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 58. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 59. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 86. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 87. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 104. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 105. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 140. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 141. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 160. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 161. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 166. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 167. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 172. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 173. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 178. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 179. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 184. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 185. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 196. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 197. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 214. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 215. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 220. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 221. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 226. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 227. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 250. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 251. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 268. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 269. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • A&T Corporation
  • Abbott Laboratories
  • Advin Health Care
  • Becton, Dickinson and Company
  • Beijing Succeeder Technology Inc.
  • Bio Group Medical System SRL
  • Bio-Rad Laboratories, Inc.
  • Coagulation Sciences LLC
  • Danaher Corporation
  • Drucker Diagnostics, LLC
  • F. Hoffmann-La Roche Ltd
  • Genrui Biotech Inc.
  • Helena Laboratories Corporation
  • HORIBA, Ltd.
  • Maccura Biotechnology Co., Ltd.
  • Medtronic PLC
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Sekisui Chemical Co., Ltd.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Siemens Healthineers AG
  • Stago Group
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Tulip Diagnostics (P) Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.96 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030 - Product Image

Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032 - Product Image

Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032

  • Report
  • 139 Pages
  • Global
From
Coagulation Analyzer Market Forecast to 2030 - Global Analysis By Product Type, Test, Technology, End User, and Geography - Product Image

Coagulation Analyzer Market Forecast to 2030 - Global Analysis By Product Type, Test, Technology, End User, and Geography

  • Report
  • 205 Pages
  • Global
From
Coagulation Testing - Global Strategic Business Report - Product Image

Coagulation Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Point-of-Care (POC) Coagulation Testing Global Market Report 2024 - Product Image

Point-of-Care (POC) Coagulation Testing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Blood Coagulation Test Market

The Blood Coagulation Test market is a subset of the larger Coagulation and Hemostasis Testing market. It is used to measure the ability of blood to clot, which is an important indicator of overall health. Blood coagulation tests are used to diagnose and monitor a variety of conditions, including bleeding disorders, clotting disorders, and other conditions that affect the body's ability to form clots. These tests measure the activity of clotting factors, the presence of anticoagulants, and the time it takes for a clot to form. The results of these tests can help diagnose and monitor a variety of conditions, as well as guide treatment decisions. Some companies in the Blood Coagulation Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, and Beckman Coulter. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.